What is LOPJLB’s current signal on ENGN?

LOPJLB’s latest quantitative signal on enGene Holdings Inc. (ENGN) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is ENGN in?

enGene Holdings Inc. (ENGN) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does enGene Holdings Inc. (ENGN) do?

Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene voraplasmid. This innovative non-viral immunotherapy …

Where is enGene Holdings Inc. based / listed?

enGene Holdings Inc. is based in CA, listed on NASDAQ.

enGene Holdings Inc. (ENGN)

COMPARE

Healthcare · Biotechnology · NASDAQ · CA

$1.78+1.71%Close

SELLRECOVERY · day 36

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $91M
Short % float: 5.57%

Days to cover: 1.7
SI change: -2.1%

Industry peers

FMP comparable companies · ranked by market cap

ANROSELLAlto Neuroscience, Inc.$870MCRISISQ 17$24.80+2.17%
ANNXSELLAnnexon, Inc.$687MRECOVERYQ -8$4.19-0.25%
ALTSELLAltimmune, Inc.$532MCRISISQ -5$2.73-2.26%
SLNSELLSilence Therapeutics plc$503MCRISISQ 0$10.64-3.05%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news